Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc. - PE Ratioverified

KPRX

Price:

$2.53

Market Cap:

$11.21M

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently in Phase 2 trials for addressing the ocular manifestations of rheumatoid arthritis, as well as non-infectious posterior uveitis. Furthermore, Kiora i...[Read more]

Industry

Biotechnology

IPO Date

2015-02-13

Stock Exchange

NASDAQ

Ticker

KPRX

The PE Ratio as of June 2026 (TTM) for Kiora Pharmaceuticals, Inc. (KPRX) is -0.94

According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.94. This represents a change of -103.43% compared to the average of 27.40 of the last 4 quarters.

Kiora Pharmaceuticals, Inc. (KPRX) Historical PE Ratio (quarterly & annually)

How has KPRX PE Ratio performed in the past?

The mean historical PE Ratio of Kiora Pharmaceuticals, Inc. over the last ten years is -10.65. The current -0.94 PE Ratio has changed 782.66% with respect to the historical average. Over the past ten years (40 quarters), KPRX's PE Ratio was at its highest in in the September 2025 quarter at 112.10. The PE Ratio was at its lowest in in the March 2021 quarter at -31.95.

Quarterly (TTM)
Annual

Average

-10.65

Median

-8.85

Minimum

-40.42

Maximum

3.55

Kiora Pharmaceuticals, Inc. (KPRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 194.22%

Maximum Annual PE Ratio = 3.55

Minimum Annual Increase = -1930.82%

Minimum Annual PE Ratio = -40.42

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.76-121.35%
20243.55-1930.82%
2023-0.19-88.35%
2022-1.66-79.18%
2021-7.99-68.25%
2020-25.17-37.72%
2019-40.42194.22%
2018-13.7432.24%
2017-10.396.97%
2016-9.71-46.37%

Kiora Pharmaceuticals, Inc. (KPRX) Average PE Ratio

How has KPRX PE Ratio performed in the past?

The current PE Ratio of Kiora Pharmaceuticals, Inc. (KPRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

0.87

5-year avg

-1.41

10-year avg

-10.65

Kiora Pharmaceuticals, Inc. (KPRX) PE Ratio vs. Peers

How is KPRX’s PE Ratio compared to its peers?

Kiora Pharmaceuticals, Inc.’s PE Ratio is less than Aprea Therapeutics, Inc. (-0.41), less than BioCardia, Inc. (-0.94), less than Acurx Pharmaceuticals, Inc. (-0.31), less than IN8bio, Inc. (-0.38), greater than Creative Medical Technology Holdings, Inc. (-1.08), less than Aptevo Therapeutics Inc. (-0.01), less than HCW Biologics Inc. (-0.13), less than Phio Pharmaceuticals Corp. (-0.72), less than Adial Pharmaceuticals, Inc. (-0.27), less than TransCode Therapeutics, Inc. (-0.10),

Build a custom stock screener for Kiora Pharmaceuticals, Inc. (KPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kiora Pharmaceuticals, Inc. (KPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kiora Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the highest PE Ratio for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the 3-year average PE Ratio for Kiora Pharmaceuticals, Inc. (KPRX)?

What is the 5-year average PE Ratio for Kiora Pharmaceuticals, Inc. (KPRX)?

How does the current PE Ratio for Kiora Pharmaceuticals, Inc. (KPRX) compare to its historical average?